| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/30/2011 | US20110158906 Targeted block copolymer micelles |
| 06/30/2011 | US20110158905 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use |
| 06/30/2011 | US20110155130 Dronabinol Treatment for Migraines |
| 06/30/2011 | CA2785360A1 Treating critically ill patients with intravenous ibuprofen |
| 06/30/2011 | CA2785284A1 Novel aryl urea derivative |
| 06/30/2011 | CA2784996A1 Formulation comprising 1 h-quinazoline-2,4-dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof |
| 06/30/2011 | CA2784845A1 Use of polysaccharides for treating stress and anxiety |
| 06/30/2011 | CA2784242A1 New aminotetraline derivatives |
| 06/30/2011 | CA2783714A1 Carboxamide compounds and their use as calpain inhibitors iv |
| 06/30/2011 | CA2783704A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/30/2011 | CA2783258A1 Pteridinones as inhibitors of polo-like kinase |
| 06/30/2011 | CA2783209A1 Amino-heteroaryl derivatives as hcn blockers |
| 06/30/2011 | CA2776342A1 Agomelatine and pharmaceutical compositions thereof |
| 06/29/2011 | EP2339490A1 Method for determining medication efficacy |
| 06/29/2011 | EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/29/2011 | EP2338915A2 Anti-VEGF antibodies |
| 06/29/2011 | EP2338908A1 Peptides containing post-translational modifications and their use in the treatment of autoimmune pathologies |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338899A1 Peptides for activation and inhibition of delta PKC |
| 06/29/2011 | EP2338892A1 Prostate specific membrane antigen inhibitors |
| 06/29/2011 | EP2338891A2 Method of forming hydromorphinone compositions |
| 06/29/2011 | EP2338889A1 Diazacyclic compounds having affinity for opioid receptors |
| 06/29/2011 | EP2338886A2 Naphthalene derivatives |
| 06/29/2011 | EP2338873A1 New aminotetraline derivatives |
| 06/29/2011 | EP2338517A1 Method for treatment or prevention of disease associated with functional disorder of regulatory T cell |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338510A1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 06/29/2011 | EP2338503A1 Composition for improving brain function and method for improving brain function |
| 06/29/2011 | EP2338502A1 Composition for improving brain function and method for improving brain function |
| 06/29/2011 | EP2338501A1 Composition for improving brain function and method for improving brain function |
| 06/29/2011 | EP2338494A1 Noribogaine in the treatment of pain and drug addiction |
| 06/29/2011 | EP2338492A1 Methods and compositions for the treatment of alzheimer |
| 06/29/2011 | EP2338490A2 Combinations Useful for the Treatment of Neuronal Disorders |
| 06/29/2011 | EP2338483A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders using choline |
| 06/29/2011 | EP2338482A2 Methods for treating neuropsychiatric disorders |
| 06/29/2011 | EP2337783A1 Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine d3 receptors |
| 06/29/2011 | EP2337778A1 Methods of treating a botulinum toxin related condition in a subject |
| 06/29/2011 | EP2337576A1 Treatment of mood and anxiety disorders |
| 06/29/2011 | EP2337566A1 Combinations for the treatment of migraine |
| 06/29/2011 | EP2039354B1 Compounds blocking the nmda receptor channel and pharmaceutical agent using the same |
| 06/29/2011 | EP2004605B1 Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists |
| 06/29/2011 | EP1503788B1 Treatment of alpha-galactosidase a deficiency |
| 06/29/2011 | EP1499313B1 Heterocyclic derivatives as opioid receptor modulators |
| 06/29/2011 | CN201880198U Treating bag of peripheral nerves of diabetes mellitus |
| 06/29/2011 | CN201879283U Pillow with hypnosis function |
| 06/29/2011 | CN201878752U Tobacco used for sucking high-pressure oxygen |
| 06/29/2011 | CN102112879A Stat3 and tyk2 as drug targets for neurodegenerative diseases |
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112480A 1, 6-dihydro-2H-3-oxa-6-aza-as-indacene compounds |
| 06/29/2011 | CN102112479A Buprenorphine analogs |
| 06/29/2011 | CN102112478A 5H-pyrr0l0 [2, 3-B] pyrazine derivatives for kinase modulation, and indications therefor |
| 06/29/2011 | CN102112469A Silent desensitizers of neuronal nAChR and methods of use thereof |
| 06/29/2011 | CN102112466A (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 06/29/2011 | CN102112465A Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| 06/29/2011 | CN102112441A Use of indole derivatives as NURR-1 activators for treating parkinson's disease |
| 06/29/2011 | CN102112436A Novel and efficient method for synthesis of amino acid |
| 06/29/2011 | CN102112149A Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
| 06/29/2011 | CN102112143A Methods and compositions for preventing, reducing, or treating damage caused by ischemia and ischemia-like conditions |
| 06/29/2011 | CN102108081A Novel crystal form of Iloperidone and preparation method thereof |
| 06/29/2011 | CN102107001A Application of LXR nuclear receptor agonist in treatment and prevention of autoimmune diseases |
| 06/29/2011 | CN102106998A Chinese medicine for easing and stabilizing sleep |
| 06/29/2011 | CN102106994A Treatment formula for epilepsies and manufacturing method thereof |
| 06/29/2011 | CN102106986A Method for measuring content of ferulic acid in Jieyuwan by high performance liquid chromatograph |
| 06/29/2011 | CN102106981A Compound preparation for treating spinal cord injury and preparation method thereof |
| 06/29/2011 | CN102106956A Method for controlling quality of Shenbao mixture percolating fluid |
| 06/29/2011 | CN102106942A Chinese medicinal herb for improving clinic cognitive impairment of dementia patients and preparation method thereof |
| 06/29/2011 | CN102106940A Chinese medicinal liquor for treating sciatica |
| 06/29/2011 | CN102106939A Quality control method for extract concentrated liquor of condensed pills of six ingredients with rehmannia root |
| 06/29/2011 | CN102106918A Method for simultaneously preparing volatile oil, total flavones and total alkaloids from immature bitter oranges |
| 06/29/2011 | CN102106905A Oral Chinese medicinal liquor for treating facial paralysis |
| 06/29/2011 | CN102106893A Traditional Chinese medicine preparation for relieving pain in myeleterosis |
| 06/29/2011 | CN102106891A Cardio-cerebral refreshing sustained-release soft capsules and preparation method thereof |
| 06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
| 06/29/2011 | CN102106879A Injection for treating pain diseases of pets and preparation process thereof |
| 06/29/2011 | CN102106878A Preparation method of ginkgo leaf extract liquid-filling capsule |
| 06/29/2011 | CN102106877A Production process of gingko leaf extract |
| 06/29/2011 | CN102106876A Preparation formula of novel alcohol-relieving capsules and preparation method |
| 06/29/2011 | CN102106865A Application of bi-xanthone glycoside compound in oxidative damage resistance and apoptosis inhibition |
| 06/29/2011 | CN102106850A Application of senkyunolide H to preparation of medicament for resisting tristimania, migraine and other diseases related to 5-hydroxytryptamine energy system |
| 06/29/2011 | CN102106849A Novel medicinal application of baicalein |
| 06/29/2011 | CN102106839A Alprazolam sustained-release preparation and preparation method thereof |
| 06/29/2011 | CN102106836A Almotriptan-containing buccal adhesive tablet as well as preparation method and application thereof |
| 06/29/2011 | CN102106835A Method for preparing simvastatin tablet by employing micronizing and power direct compressing technologies |
| 06/29/2011 | CN102106826A Aripiprazole solid preparation and preparation method thereof |
| 06/29/2011 | CN102106825A Solid zopiclone preparation and preparation method thereof |
| 06/29/2011 | CN102106824A Eszopiclone solid preparation and preparation method thereof |
| 06/29/2011 | CN102106818A Isoliquiritigenin micro-emulsion composition |
| 06/29/2011 | CN102106808A Solid preparation and preparation method thereof |
| 06/29/2011 | CN102106806A Method for preparing solid preparation and solid preparation |
| 06/29/2011 | CN101810783B Chinese medicinal preparation for curing cerebral hemorrhage |
| 06/29/2011 | CN101708311B Chinese medicinal preparation for treating senile dementia |
| 06/29/2011 | CN101670032B Substance obtained from sweet potato and application thereof |
| 06/29/2011 | CN101653552B Smoke-quitting alexeteric traditional Chinese medicine preparation and production method thereof |
| 06/29/2011 | CN101580525B Method for extracting salidroside, polysaccharose and tannin-type substances from rhodiola root crude drugs |
| 06/29/2011 | CN101537151B Pharmaceutical composition having effects of alleviating alcoholism, protecting liver, invigorating stomach and clearing bowels |
| 06/29/2011 | CN101518580B Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof |
| 06/29/2011 | CN101507736B Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism |
| 06/29/2011 | CN101491532B Erigeron breviscapus eye-preparation and preparation method thereof |
| 06/29/2011 | CN101433659B Pharmaceutical composition and uses thereof |